Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids

Journal of Clinical Investigation

Volumn 117, Issue 7, 2007, Pages 1866-1875

  Berquin, Isabelle M ^a   Min, Younong ^a   Wu, Ruping ^a   Wu, Jiansheng ^a   Perry, Donna ^a   Cline, J Mark ^a   Thomas, Mike J ^a   Thornburg, Todd ^a   Kulik, George ^a   Smith, Adrienne ^a   Edwards, Iris J ^a   D'Agostino Jr , Ralph ^a   Zhang, Hao ^b   Wu, Hong ^c   Kang, Jing X ^d   Chen, Yong Q ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b JIANGNAN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER MODEL; CANCER RISK; CANCER SURVIVAL; CELL DEATH; CONTROLLED STUDY; FAT INTAKE; GENETIC RISK; IMMUNOCOMPETENCE; KNOCKOUT MOUSE; LIPID DIET; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; DISEASE PROGRESSION; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; SURVIVAL RATE;

EID: 34447121230     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31494     Document Type: Article

References (51)

1. Kolonel, L.N. 2001. Fat, meat, and prostate cancer. Epidemiol. Rev. 23:72-81.
2. Wynder, E.L., Mabuchi, K., and Whitmore, W.F., Jr. 1971. Epidemiology of cancer of the prostate. Cancer. 28:344-360.
3. Breslow, N., et al. 1977. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer. Lyon, France. Int. J. Cancer. 20:680-688.
4. Dunn, J.E. 1975. Cancer epidemiology in populations of the United States - with emphasis on Hawaii and California - and Japan. Cancer Res. 35:3240-3245.
5. Haenszel, W., and Kurihara, M. 1968. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst. 40:43-68.
6. Staszewski, J., and Haenszel, W. 1965. Cancer mortality among the Polish-born in the United States. J. Natl. Cancer Inst. 35:291-297.
7. Simopoulos, A.P., Leaf, A., and Salem, N., Jr. 1999. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann. Nutr. Metab. 43:127-130.
8. Dewailly, E., et al. 2001. n-3 fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am. J. Clin. Nutr. 74:464-473.
9. Simopoulos, A.P. 1999. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 70(3 Suppl.):560S-569S.
10. Weber, P.C. 1989. Are we what we eat? Fatty acids in nutrition and in cell membranes: cell functions and disorders induced by dietary conditions. In Fish, fats and your health. Proceedings of the International Conference on Fish Lipids and Their Influence on Human Health. August 9-11. Svanoy, Norway. Svanoy Foundation. 9-18.
11. Giardiello, F.M., et al. 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328:1313-1316.
12. Jacobs, E.J., et al. 2005. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J. Natl. Cancer Inst. 97:975-980.
13. Solomon, S.D., et al. 2005. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 352:1071-1080.
14. Kang, J.X., Wang, J., Wu, L., and Kang, Z.B. 2004. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature. 427:504.
15. Edwards, I.J., et al. 2004. Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin. Clin. Cancer Res. 10:8275-8283.
16. Feinberg, A.P., and Tycko, B. 2004. The history of cancer epigenetics. Nat. Rev. Cancer. 4:143-153.
17. Feinberg, A.P. 2004. The epigenetics of cancer etiology. Semin. Cancer Biol. 14:427-432.
18. Lund, A.H., and van Lohuizen, M. 2004. Epigenetics and cancer. Genes Dev. 18:2315-2335.
19. Norrish, A.E., Skeaff, C.M., Arribas, G.L., Sharpe, S.J., and Jackson, R.T. 1999. Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br. J. Cancer. 81:1238-1242.
20. Terry, P., Lichtenstein, P., Feychting, M., Ahlbom, A., and Wolk, A. 2001. Fatty fish consumption and risk of prostate cancer. Lancet. 357:1764-1766.
21. Yang, Y.J., Lee, S.H., Hong, S.J., and Chung, B.C. 1999. Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia. Clin. Biochem. 32:405-409.
22. Freeman, V.L., et al. 2000. Prostatic levels of fatty acids and the histopathology of localized prostate cancer. J. Urol. 164:2168-2172.
23. Augustsson, K., et al. 2003. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 12:64-67.
24. Hursting, S.D., Thornquist, M., and Henderson, M.M. 1990. Types of dietary fat and the incidence of cancer at five sites. Prev. Med. 19:242-253.
25. Suzuki, H., et al. 1998. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58:204-209.
26. Vlietstra, R.J., van Alewijk, D.C., Hermans, K.G., van Steenbrugge, G.J., and Trapman, J. 1998. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res. 58:2720-2723.
27. McMenamin, M.E., et al. 1999. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res. 59:4291-4296.
28. Wang, S., et al. 2003. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 4:209-221.
29. Lin, J., Adam, R.M., Santiestevan, E., and Freeman, M.R. 1999. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res. 59:2891-2897.
30. Sharma, M., Chuang, W.W., and Sun, Z. 2002. Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. J. Biol. Chem. 277:30935-30941.
31. Manin, M., et al. 2002. Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells. Biochem. J. 366:729-736.
32. Danial, N.N., and Korsmeyer, S.J. 2004. Cell death: critical control points. Cell. 116:205-219.
33. Datta, S.R., et al. 2000. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell. 6:41-51.
34. Sastry, K.S., Smith, A.J., Karpova, Y., Datta, S.R., and Kulik, G. 2006. Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. J. Biol. Chem. 281:20891-20901.
35. She, Q.B., et al. 2005. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell. 8:287-297.
36. Klippel, A., Kavanaugh, W.M., Pot, D., and Williams, L.T. 1997. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:338-344.
37. Stocker, H., et al. 2002. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science. 295:2088-2091.
38. Chabot, M.C., Schmitt, J.D., Bullock, B.C., and Wykle, R.L. 1987. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. Biochim. Biophys. Acta. 922:214-220.
39. Wang, H.G., et al. 1999. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:339-343.
40. Chiang, C.W., et al. 2003. Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol. Cell. Biol. 23:6350-6362.
41. Larsson, S.C., Kumlin, M., Ingelman-Sundberg, M., and Wolk, A. 2004. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 79:935-945.
42. Lesche, R., et al. 2002. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis. 32:148-149.
43. Wu, X., et al. 2001. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech. Dev. 101:61-69.
44. Berquin, I.M., Min, Y., Wu, R., Wu, H., and Chen, Y.Q. 2005. Expression signature of the mouse prostate. J. Biol. Chem. 280:36442-36451.
45. Shappell, S.B., et al. 2004. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 64:2270-2305.
46. Bligh, E.G., and Dyer, W.J. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
47. Metcalfe, L.D., Schmitz, A.A., and Pelka, J.R. 1966. Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Anal. Chem. 38:514-515.
48. Schwenke, D.C., Rudel, L.L., Sorci-Thomas, M.G., and Thomas, M.J. 2002. Alpha-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits. J. Lipid Res. 43:1927-1938.
49. Rouser, G., Siakotas, A.N., and Fleisher, S. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids. 1:85-86.
50. DeLong, C.J., Baker, P.R., Samuel, M., Cui, Z., and Thomas, M.J. 2001. Molecular species composition of rat liver phospholipids by ESI-MS/MS: the effect of chromatography. J. Lipid Res. 42:1959-1968.
51. Liu, J., et al. 2002. Mediation of the DCC apoptotic signal by DIP13 alpha. J. Biol. Chem. 277:26281-26285.